Oncosec Medical Incorporated (ONCS) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jan 31 2023 to Jan 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Oncosec Medical Incorporated  (NASDAQ: ONCS)


Oncosec Medical Incorporated's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Oncosec Medical Incorporated's ROI in the second quarter of 2023?
Oncosec Medical Incorporated recorded a cumulative net loss of $-29 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -246.31%.

Within the Healthcare sector 1091 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 0 to 5569.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jan 31 2023)
II. Quarter		 (Oct 31 2022)
I. Quarter		 (Jul 31 2022)
IV. Quarter		 (Apr 30 2022)
III. Quarter		 (Jan 31 2022)
II. Quarter
Y / Y Investment Change TTM -72.65 % -62.97 % -43.26 % -12.67 % 33.48 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 8 15 23 30
Return On Investment (TTM) -246.31 % -171.6 % -127.98 % -107.97 % -93.88 %
ONCS's Overall Ranking # 5569 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -36.88 % -29.23 % -23.64 % -19.83 % -14.54 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -29 -32 -34 -38 -41

ONCS Company Profile >> Back to ONCS Roi Comparisons >> See Annual ONCS Return On Investment



Return On Investment ONCS's Ranking
Within: No.
Industry # 533
Sector # 1092
Overall # 5569

Return On Investment Statistics
High Average Low
-81.79 %
-154.19 %
-246.31 %
(Oct 31 2021)   (Jan 31 2023)







Financial Statements
Oncosec Medical Incorporated's II. Quarter Investments $ 2 Millions ONCS's Balance sheet
Oncosec Medical Incorporated's II. Quarter Income $ -7 Millions Quarterly ONCS's Income Statement
ONCS's Income by Division See ONCS's Income by Division


ONCS Annual Return On Investment (Jul 31 2022)
2022		 (Jul 31 2021)
2021		 (Jul 31 2020)
2020		 (Jul 31 2019)
2019		 (Jul 31 2018)
2018
Total Investments in Millions 15 48 20 25 24
Y / Y Investment Growth -68.45 % 138.88 % -18.82 % 2.12 % 106.11 %
Net Income in Millions -34 -45 -42 -30 -39
Y / Y Net Income Growth - - - - -
Annual Return On Investment -224.2 % -93.49 % -208.91 % -121.52 % -160.42 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ONCS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ONCS's Competitors
Subscribers only: Roi for Oncosec Medical Incorporated's Suppliers
Subscribers only: Return On Investment for ONCS's Customers

Other Ratios
ONCS's Roa ONCS's Inventory Turnover Ratio ONCS's Growth Rates ONCS's Dividend Statistics
ONCS's Profitability Ratios ONCS's Asset Turnover Ratio ONCS's Dividend Growth
ONCS's Roe ONCS's Valuation Ratios ONCS's Financial Strength Ratios ONCS's Dividend Payout Ratio



Companies with similar Return On Investment at Jan 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.